L

    LifeMD Inc (LFMD)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $3.09
    -0.05 (-1.59%)

    Market Cap: $151.35M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(14/24)
    Avg Surprise
    -38.02%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.02 - $0.01
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.17+3500.0%
    60d ago$0.17+3500.0%
    30d ago$0.17+3500.0%
    7d ago$0.17+3500.0%
    Current$-0.01
    Revenue Consensus
    $49M
    Range$46M - $51M
    8 analysts
    Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.04 - $0.07
    2 analysts
    Revenue Consensus
    $61M
    Range$59M - $64M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.01---
    Jun 26
    		$-0.16$-0.20+20.00%Beat-1500.0%
    Mar 26
    		$-0.15$-0.12-29.91%Miss-605.3%
    Dec 25
    		$0.06$0.09-33.33%Miss-71.4%
    Sep 25
    		$-0.08$0.05-260.00%Miss-188.9%
    Jun 25
    		$-0.01N/A-105.56%Miss-116.7%
    Mar 25
    		$0.03N/A-78.57%Miss+200.0%
    Dec 24
    		$0.21$0.14+50.00%Beat+275.0%
    Sep 24
    		$0.09$0.07+28.57%Beat+12.5%
    Jun 24
    		$0.06$0.04+50.00%Beat+20.0%
    Mar 24
    		$0.01$-0.01+200.00%Beat+106.7%
    Dec 23
    		$-0.12$-0.14+14.29%Beat+70.0%
    Sep 23
    		$0.08$0.03+166.67%Beat+366.7%
    Jun 23
    		$0.05$0.03+66.67%Beat+122.7%
    Mar 23
    		$-0.15$-0.16+6.25%Beat+67.4%
    Dec 22
    		$-0.40$-0.18-122.22%Miss-37.9%
    Sep 22
    		$-0.03N/A+75.00%Beat+91.7%
    Jun 22
    		$-0.22$-0.23+4.35%Beat+56.9%
    Mar 22
    		$-0.46$-0.36-27.78%Miss+4.2%
    Dec 21
    		$-0.29$-0.39+25.64%Beat+88.7%
    Sep 21
    		$-0.36$-0.49+26.53%Beat+65.0%
    Jun 21
    		$-0.51$-0.45-13.33%Miss+79.9%
    Mar 21
    		$-0.48$-0.44-9.09%Miss-118.2%
    Dec 20
    		$-2.56$-0.24-966.67%Miss-3557.1%
    Sep 20
    		$-1.03$-1.03+0.00%Beat-1044.4%
    Jun 20
    		$-2.54N/AN/ABeat-2809.5%
    Mar 20
    		$-0.22N/AN/ABeat-210.3%
    Dec 19
    		$-0.07N/AN/ABeat+17.7%
    Sep 19
    		$-0.09N/AN/ABeat-61.3%
    Jun 19
    		$-0.09N/AN/ABeat-24.2%
    Mar 19
    		$-0.07N/AN/ABeat-204.6%
    Dec 18
    		$-0.09N/AN/ABeat-240.4%
    Sep 18
    		$-0.06N/AN/ABeat+27.4%
    Jun 18
    		$-0.07N/AN/ABeat-190.1%
    Mar 18
    		$0.07N/AN/ABeat+148.8%
    Dec 17
    		$-0.03N/AN/ABeat+71.5%
    Sep 17
    		$-0.08N/AN/ABeat-133.7%
    Jun 17
    		$0.08N/AN/ABeat-
    Mar 17
    		$-0.14N/AN/ABeat-
    Dec 16
    		$-0.09N/AN/ABeat-
    Sep 16
    		$-0.03N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-9.32EV/EBITDA26.79x
    Price/FCF-13.38xFCF Yield-7.47%
    Profitability
    Profit Margin0.11%Operating Margin-15.10%
    ROE-516.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-12.68x
    Current Ratio0.90xQuick Ratio0.84x
    Trading Statistics
    Beta2.06Avg Volume972.01K
    52-Week High$7.3252-Week Low$2.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.24
    SMA 20$3.37
    SMA 50$3.91
    SMA 200$3.88
    EMA 10$3.24
    EMA 20$3.39
    EMA 50$3.75
    EMA 200$4.39

    MACD

    Line: -0.21Signal: -0.22Hist: 0.01

    ADX

    ADX: 39.1+DI: 9.8-DI: 27.0

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down32.0
    PSAR$3.72

    Bollinger Bands

    Upper Band$3.77
    Lower Band$2.97
    %B Position2357%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    35.9

    Momentum Oscillators

    Stoch %K9.9
    Stoch %D17.4
    Williams %R-97.5
    ROC (10d)-6.9%
    Momentum-0.23
    CCI (20d)-112.0
    MFI (14d)43.6

    Volatility Measures

    ATR (14d)$0.21(6.7%)
    StdDev (20d)0.20
    Hist Vol63.0%(High)

    Volume Flow

    VWAP$3.15
    OBV4.8M
    AD Line-540.7K
    CMF (20d)0.085

    Volume Metrics

    Avg Vol (20d)990.6K
    Vol Ratio0.7x
    VWMA (20d)$3.43

    Pivot Points

    R3$3.41
    R2$3.35
    R1$3.25
    Pivot Point$3.19
    S1$3.09
    S2$3.03
    S3$2.93

    Advanced Oscillators

    TSI-23.87
    Ultimate Osc36.3
    KST-183.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$47.28M$50.16M$46.87M$60.17M$49.02M$50.89M$64.25M$53.27M$50.66M$44.14M$44.86M$38.61M
    Cost of Revenue$5.28M$5.93M$8.52M$7.41M$6.84M$8.14M$9.43M$5.01M$5.02M$4.60M$5.36M$4.78M
    Gross Profit$42.00M$44.24M$38.35M$52.76M$42.18M$42.75M$54.82M$48.26M$45.64M$39.54M$39.50M$33.83M
    Operating Expenses$49.13M$53.17M$39.45M$54.73M$44.53M$43.93M$53.81M$52.26M$51.94M$45.72M$41.68M$38.40M
    R&D$1.79M$1.80M$1.82M$2.85M$1.82M$1.86M$2.41M$2.61M$2.40M$2.09M$2.00M$1.50M
    SG&A$19.30M$21.50M$15.54M$22.41M$20.55M$19.80M$25.54M$23.03M$23.16M$19.45M$19.29M$17.13M
    Operating Income$-7,129,601$-8,929,072$-1,097,718$-1,969,214$-2,346,886$-1,181,717$1.02M$-3,996,274$-6,305,566$-6,171,245$-2,171,536$-4,569,381
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$-45,660$-56,476$190,791$1.42M$660,787$463,638$614,074$558,597$531,468$477,678$622,685$713,766
    Income Before Tax$-7,083,941$-8,872,596$-1,073,639$-3,387,521$-3,007,673$-1,645,355$404,168$-4,554,871$-6,837,034$-6,648,923$-2,794,221$-5,283,147
    Income Tax Expense$0$0$13,898$169,134$0$0$0$232,523$0$0$0$0
    Net Income$-7,083,941$-8,872,596$-1,496,800$-3,556,655$-1,114,589$348,067$234,691$-4,787,394$-6,837,034$-6,648,923$-3,222,221$-5,283,147
    EBITDA$-5,091,217$-6,932,845$876,088$1.06M$-461,097$610,135$3.67M$-1,338,914$-3,916,897$-3,971,516$-130,364$-2,754,859
    EBIT$-7,129,601$-8,929,072$-1,073,639$-1,969,214$-2,346,886$-1,181,717$1.02M$-3,996,274$-6,305,566$-6,171,245$-2,171,536$-4,569,381
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LFMD

    News

    LifeMD (LFMD) Stock Sees Fair Value Cut After Analysts Lower Targets On Weaker Guidance

    Analysts have reduced their fair value estimates and price targets for LifeMD (LFMD) stock following weaker than expected Q2 results and a cut to FY26 guidance. Despite some long-term bullish outlooks on new initiatives, concerns about declining active subscribers and increased investment costs are driving more cautious valuations. The updated fair value for LFMD has decreased by approximately 18% to US$8.13.

    Yahoo Finance•8/23/26•
    Bearish

    LifeMD (NASDAQ: LFMD) insider reports stock trade

    LifeMD, Inc. (NASDAQ: LFMD) Director Joan LaRovere reported an insider stock transaction, acquiring 35,000 shares of common stock through a grant/award on August 11, 2026. These restricted shares will vest on June 1, 2027, bringing LaRovere's direct holdings to 142,050 shares. The filing of this Form 4 indicates a neutral impact and sentiment on the company's stock.

    Stock Titan•8/18/26•
    Neutral

    (LFMDP) as a Liquidity Pulse for Institutional Tactics

    This article provides an AI-generated analysis of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), indicating a neutral sentiment and a mid-channel oscillation pattern. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal strengths and support/resistance levels, emphasizing a wait-and-see approach due to the neutral sentiment across all horizons.

    Stock Traders Daily•8/16/26•
    Neutral

    Russell Investments Group Ltd. Buys 309,436 Shares of LifeMD, Inc. $LFMD

    Russell Investments Group Ltd. significantly increased its stake in LifeMD, Inc. by 5,801.2% in the second quarter, acquiring 309,436 additional shares and now owning 314,770 shares valued at approximately $1.3 million. This increase occurred despite LifeMD missing its latest quarterly earnings and revenue estimates. Analysts maintain a "Moderate Buy" consensus rating for LifeMD with an average price target of $7.57, though several earnings forecasts have been lowered due to profitability concerns.

    MarketBeat•8/16/26•
    Neutral

    Walleye Capital LLC Purchases New Stake in LifeMD, Inc. $LFMD

    Walleye Capital LLC has acquired a new stake of 323,898 shares in LifeMD, Inc. (NASDAQ:LFMD) during the second quarter, valued at approximately $1.34 million, giving them a 0.67% ownership. This comes as institutional investors now collectively own 35.52% of the telehealth company. Despite LifeMD missing earnings and revenue estimates for the recent quarter, analysts maintain a "Moderate Buy" consensus with an average price target of $7.57, though some have lowered their targets and the company is expected to remain unprofitable in the near term.

    MarketBeat•8/15/26•
    Somewhat-Bearish

    Frequently Asked Questions About LFMD

    Does LFMD pay dividends?
    LifeMD Inc (LFMD) does not currently pay a regular dividend.
    What is LFMD's market cap?
    LifeMD Inc (LFMD) has a market capitalization of $151.35M with a current stock price of $3.09.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In